Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.21 -0.48 (-3.51%)
At close: Oct 1, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) Cash from Financing Activities (2018 - 2026)

Updated

Arcturus Therapeutics Holdings (ARCT) posted Cash from Financing Activities of $16,000 for Q1 2026, down 99.9% from $15.2 million a year earlier and down 99.9% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Cash from Financing Activities (2018 - 2026) Analysis & Trends

For FY2025, Arcturus Therapeutics Holdings' Cash from Financing Activities came in at $13.38 million, up 147.0% from FY2024.

  • Annual Cash from Financing Activities shows a five-year compound annual growth rate of -50.2% (FY2020 to FY2025).
  • In prior years, Arcturus Therapeutics Holdings' Cash from Financing Activities was $5.42 million in FY2024, -$24.09 million in FY2023, -$2.86 million in FY2022 and $48.02 million in FY2021 (-89.0%).
  • Quarterly Cash from Financing Activities has run from a low of -$27.36 million in Q1 2023 to a high of $21.84 million in Q3 2023 over five years.
  • On a year-over-year basis, Cash from Financing Activities increased in two of the last four quarters, with growth averaging 118.6%.
  • The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q1 2025, with growth of 594.5%; the weakest was Q2 2021, with a decline of 99.9%.
  • According to Business Quant data, Cash from Financing Activities for the three prior quarters was $11.69 million (Q4 2025), $1.23 million (Q3 2025) and -$14.73 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Arcturus Therapeutics Holdings 389.11 Mn -425.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 16,000.00
Dec 31, 2025 11.69 Mn
Sep 30, 2025 1.23 Mn
Jun 30, 2025 -14.73 Mn
Mar 31, 2025 15.20 Mn
Dec 31, 2024 134,000.00
Sep 30, 2024 693,000.00
Jun 30, 2024 2.40 Mn
Mar 31, 2024 2.19 Mn
Dec 31, 2023 -18.66 Mn
Sep 30, 2023 21.84 Mn
Jun 30, 2023 94,000.00
Mar 31, 2023 -27.36 Mn
Dec 31, 2022 -2.23 Mn
Sep 30, 2022 -1.22 Mn
Jun 30, 2022 257,000.00
Mar 31, 2022 336,000.00
Dec 31, 2021 230,000.00
Sep 30, 2021 692,000.00
Jun 30, 2021 82,000.00
API Access

Arcturus Therapeutics Holdings Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ARCT&period=max&api_key=YOUR_API_KEY